New study aims to boost timely colonoscopies and prevent colon cancer in High-Risk patients

NCT ID NCT06376565

Recruiting now Knowledge-focused Sponsor: Jonsson Comprehensive Cancer Center Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a program that uses reminders, scheduling help, and electronic health record tools to encourage patients with high-risk colon polyps to get a follow-up colonoscopy within 3 years. About 1,680 patients and their healthcare providers will take part. The goal is to see if these system-level changes can increase the number of people who complete the recommended surveillance, which could help prevent colorectal cancer.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Multilevel health system intervention (clinic reminders, EHR tools, scheduling support)
What this could lead to: If successful, this could provide a practical, scalable way to ensure more people with high-risk polyps get their recommended follow-up colonoscopy on time, potentially reducing colorectal cancer cases.
What could go wrong: This is a behavioral and system-level study, not a drug trial. Success depends on clinic and patient participation, and results may vary across different healthcare settings. It won't directly treat or cure cancer.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLORECTAL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

colorectal neoplasm colorectal carcinoma prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COLORECTAL CARCINOMA

Contacts and locations

Locations

UCLA / Jonsson Comprehensive Cancer Center
RECRUITING

Los Angeles, California, 90095, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.